Lotus Pharmaceuticals, Inc.
Symbool: LTUS
PNK
0.00401
USDMarktprijs vandaag
-651.6106
Koers/Winst Verhouding
-3.8330
Koers/Winst Groei Verhouding
0.11M
MRK Kapitalisatie
- 0.00%
DIV Rendement
Lotus Pharmaceuticals, Inc. (LTUS) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.net-receivables | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.other-current-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.total-current-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.total-non-current-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.total-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.account-payables | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.short-term-debt | 0 | 0.1 | 0.1 | 0.1 | |||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0 | 0 | |||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||
balance-sheet.row.other-current-liab | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.total-liab | 0 | 0.1 | 0.1 | 0.1 | |||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.common-stock | 0 | 2.7 | 2.7 | 2.9 | |||||||||||
balance-sheet.row.retained-earnings | 0 | -32.8 | -32.8 | -32.8 | |||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | -2.7 | 0 | |||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 30 | 32.7 | 29.7 | |||||||||||
balance-sheet.row.total-stockholders-equity | 0 | -0.1 | -0.1 | -0.1 | |||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.total-equity | 0 | -0.1 | -0.1 | -0.1 | |||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||
Total Investments | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.total-debt | 0 | 0.1 | 0.1 | 0.1 | |||||||||||
balance-sheet.row.net-debt | 0 | 0.1 | 0.1 | 0.1 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.change-in-working-capital | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.other-non-cash-items | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | 0 | 0.1 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.net-change-in-cash | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.operating-cash-flow | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.capital-expenditure | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.free-cash-flow | 0 | 0 | 0 | 0 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.cost-of-revenue | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.gross-profit | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.operating-expenses | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.cost-and-expenses | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.total-operating-expenses | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.operating-income | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.income-before-tax | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.income-tax-expense | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.net-income | 0 | 0 | 0 | 0 |
Vaak gestelde vragen
Wat is Lotus Pharmaceuticals, Inc. (LTUS) totale activa?
Lotus Pharmaceuticals, Inc. (LTUS) totale activa is 5681.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.000.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.000.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.000.
Wat is Lotus Pharmaceuticals, Inc. (LTUS) nettowinst (netto-inkomen)?
De nettowinst is -18812.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 116683.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 18812.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.